New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has found
New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October)
Is it true progression or pseudoprogression in tumor growth?
Standing at a crosswalk, the signal changes from “don’t walk,” to “walk.” You might step out into the street straight away, or you might look
People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions
Using a new recipe for growing blood vessels from living lung tissue in the lab, a University of Virginia School of Engineering and Applied Science
VLS-01, a proprietary oral transmucosal film (OTF) formulation of DMT, was well-tolerated with a favorable safety profile Pharmacokinetic and pharmacodynamic data confirmed systemic delivery of
Cybin Inc. positive news cycle keeps churning out positive developments. Today, the company announced the successful completion of dosing for the final cohort within the
–Topline efficacy data expected in Q4 2023 – – Preparations are underway to scale the CYB003 program to a potential Phase 3 study in early
PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — is pleased to share its 2023 White Paper on the future of psychedelic access